RESUMEN
Solid tumors in childhood are extremely rare entities, which are usually treated in specialized centers. Diagnosis and therapy are carried out according to a joint European protocol, whereby the pathological evaluation and therapy are carried out according to international guidelines. For the correct diagnosis and/or therapy of most tumors, analysis of specific genetic changes is mandatory; therefore, tumors have to be adequately sampled for parallel genetic analysis during the pathological work-up. A second opinion reference of the histopathological assessment is part of the international guidelines. Neuroblastomas, congenital mesoblastic nephromas and rhabdoid tumors are examples of solid tumors in childhood that are not restricted to one organ and occur exclusively during childhood.
Asunto(s)
Neoplasias/patología , Enfermedades Raras , Niño , Preescolar , Femenino , Adhesión a Directriz , Humanos , Lactante , Recién Nacido , Neoplasias Renales/diagnóstico , Neoplasias Renales/genética , Neoplasias Renales/patología , Neoplasias Renales/terapia , Neoplasias/diagnóstico , Neoplasias/genética , Neoplasias/terapia , Nefroma Mesoblástico/diagnóstico , Nefroma Mesoblástico/genética , Nefroma Mesoblástico/patología , Nefroma Mesoblástico/terapia , Neuroblastoma/diagnóstico , Neuroblastoma/genética , Neuroblastoma/patología , Neuroblastoma/terapia , Embarazo , Proteínas Proto-Oncogénicas c-myc/genética , Derivación y Consulta , Tumor Rabdoide/diagnóstico , Tumor Rabdoide/genética , Tumor Rabdoide/patología , Tumor Rabdoide/terapia , Proteína SMARCB1/genéticaAsunto(s)
Educación de Postgrado en Medicina , Medicina/tendencias , Patología/educación , Patología/tendencias , Pediatría/educación , Pediatría/tendencias , Aborto Espontáneo/patología , Austria , Niño , Preescolar , Anomalías Congénitas/patología , Femenino , Feto/patología , Predicción , Alemania , Humanos , Lactante , Recién Nacido , Neoplasias/patología , Placenta/patología , Embarazo , SuizaRESUMEN
We describe, to our knowledge, the first case of progressive neonatal liver failure due to neonatal haemochromatosis (NH) occurring in an infant with a gastroschisis and review the literature regarding these two conditions. A 1,665 g male infant with antenatally diagnosed gastroschisis was born with a severe coagulopathy, anaemia, thrombocytopenia, hypoglycaemia and jaundice. He developed progressive liver failure, complicated by necrotising enterocolitis. Serum ferritin was elevated at 1,459 microg/L. He died on day 40 and a limited post-mortem examination confirmed significant hepatic siderosis with fibrosis and cholestasis, and siderosis of the pancreas. Although no genetic aetiology for gastroschisis has been identified, an occasional inherited tendency has been observed. There is also evidence to support an autosomal recessive inheritance in NH.
Asunto(s)
Gastrosquisis/complicaciones , Hemocromatosis/etiología , Diagnóstico Diferencial , Resultado Fatal , Gastrosquisis/diagnóstico , Hemocromatosis/diagnóstico , Humanos , Recién Nacido , MasculinoRESUMEN
BACKGROUND: The optimal management of inoperable desmoid tumors is still unclear. We report a 26 year-old female patient with familial adenomatous polyposis suffering from a recurrent inoperable intraabdominal desmoid tumor and its sequential treatment. METHODS: Treatment strategies included low-dose tamoxifen (30 mg orally per day), high-dose tamoxifen (90 mg orally per day), and a subsequent combination of goserelin acetate (3.6 mg subcutaneously once every four weeks) plus low-dose tamoxifen, medroxyprogesterone acetate (1000 mg orally per day) and interferon gamma (3 Mio IU subcutaneously 3 times a week). RESULTS: The combination of goserelin acetate and low-dose tamoxifen resulted in a decrease in tumour size and a complete relief of symptoms for 17 months. Thereafter the tumor progressed and again growth was stopped with interferon gamma therapy for another 6 months. All other treatment modalities had no effect. CONCLUSIONS: This study demonstrates long-term regression of a desmoid tumor with combined endocrine therapy using goserelin acetate plus tamoxifen. Tumor progression after 17 months was again stopped by a combination of interferon-gamma and goserelin acetate.